Sitagliptin NOBEL 25 mg
Sitagliptin NOBEL 25 mg is a medicine authorised by Swissmedic under authorisation number 68680. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 November 2022 and the authorisation is limited until 16 November 2027. ATC code A10BH01 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 68680 |
|---|---|
| Name | Sitagliptin NOBEL 25 mg |
| Full name | Sitagliptin NOBEL 25 mg, Filmtabletten |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BH01 |
| First authorisation | 17 November 2022 |
| Authorisation validity | 16 November 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sitagliptin NOBEL 25 mg, Filmtabletten | B | 17 November 2022 |
| 2 | Sitagliptin NOBEL 50 mg, Filmtabletten | B | 17 November 2022 |
| 3 | Sitagliptin NOBEL 100 mg, Filmtabletten | B | 17 November 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 2 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 3 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 4 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 5 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 6 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sitagliptin NOBEL 25 mg authorised in Switzerland?
Yes. Sitagliptin NOBEL 25 mg is authorised by Swissmedic under authorisation number 68680, data as of 01 September 2026. The authorisation is limited until 16 November 2027.
Which dispensing category does Sitagliptin NOBEL 25 mg have?
Sitagliptin NOBEL 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sitagliptin NOBEL 25 mg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.